Tyrosine kinase signalling in breast cancer: insulin-like growth factors and their receptors in breast cancer.
about
BAD: a good therapeutic target?Akt kinases in breast cancer and the results of adjuvant therapyDecreased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor promotes growth of human breast cancer cellsInsulin-like growth factors and insulin-like growth factor binding proteins in mammary gland function.Tyrosine kinase signalling in breast cancerTyrosine kinase signalling in breast cancer: modulation of tyrosine kinase signalling in human breast cancer through altered expression of signalling intermediates.Glucose metabolism in gastric cancer: The cutting-edgeObesity and breast cancer: a multipartite connection.Northwestern profiling of potential translation-regulatory proteins in human breast epithelial cells and malignant breast tissues: evidence for pathological activation of the IGF1R IRES.GnRH receptor activation competes at a low level with growth signaling in stably transfected human breast cell lines.The reciprocal regulation of gamma-synuclein and IGF-I receptor expression creates a circuit that modulates IGF-I signaling.The human IGF1R IRES likely operates through a Shine-Dalgarno-like interaction with the G961 loop (E-site) of the 18S rRNA and is kinetically modulated by a naturally polymorphic polyU loop.The mRNA expression of IGF-1 and IGF-1R in human breast cancer: association with clinico-pathological parameters.Evidence for prostacyclin and cAMP upregulation by bradykinin and insulin-like growth factor 1 in vascular smooth muscle cells.Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptorIntegrity of mTORC2 is dependent on the rictor Gly-934 site.The therapeutic potential of agents targeting the type I insulin-like growth factor receptor.Obesity Correlation With Metastases Development and Response to First-Line Metastatic Chemotherapy in Breast CancerHyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes.Obesity-driven inflammation and cancer risk: role of myeloid derived suppressor cells and alternately activated macrophages.BRCA1 inhibits membrane estrogen and growth factor receptor signaling to cell proliferation in breast cancerSmall molecule inhibitors of the IGF-1R/IR axis for the treatment of cancer.Theoretical and computational studies of peptides and receptors of the insulin family.Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells.Activation of BAD by therapeutic inhibition of epidermal growth factor receptor and transactivation by insulin-like growth factor receptor.Caspase-mediated Cleavage of Insulin Receptor Substrate.Is obesity always a risk factor for all breast cancer patients? c-erbB2 expression is significantly lower in obese patients with early stage breast cancer.
P2860
Q24795051-CE735557-D7F2-4790-8B83-07A266D92C8BQ24795435-3E26FF79-E444-4B4B-8521-049B5801DFA4Q24798573-1EAEA17B-2CD9-40B0-9EBF-8A9BCD429E73Q24800144-8756263E-65B1-44B8-8296-5122BEC803FCQ24802908-3CAA7BEB-0591-4E06-B2A6-35D5ECFA5304Q24803027-E6E63F52-3345-4FBF-9FE4-3EBBB34DFBAFQ26766098-0DF8D68A-1B78-4748-9293-DF21F094603FQ33566125-A772ABB5-7B33-4B3D-8CEB-C1B18177B68AQ33843662-702A1858-5658-4F53-B8B9-46DE0CE6F6F0Q34066386-33254889-D2B5-4DE6-97E7-906FECE5B8D8Q34155259-8789E9D0-5427-43CE-9997-F588ED8F4CC6Q34380167-D7C749DC-EE5F-498E-BF06-8BBE49B63ECAQ34690787-710DFD8F-A89D-4B16-8519-4919ADDE8399Q35082788-38B810A8-1D50-43B5-B92F-A47E2F4706D3Q35234141-DC0468B2-F9C5-4FFD-88DD-083C3261F11AQ35834752-7BCB987A-EE65-485A-BBBB-FD1946FBA58CQ35964712-678CF702-834E-4927-8B95-F1C3994DB66CQ36318861-A572EBCF-12C1-4BE6-99C0-80CF890873C2Q36393112-FB78E3FE-05A4-4020-B5A5-CAFFC304D61AQ36562906-12E10A29-2343-4750-A139-555F2496B69BQ36732507-2599E77F-93AB-4895-BB45-8CD386DF40BCQ37859024-59A7AA15-889F-4D73-9D91-648446BFD0A4Q38354696-69BA5A69-A2D3-4C8E-A25B-354B7E73DA56Q40219858-01275293-26D2-465D-859E-8CCBE1F6CDC9Q40732059-93497990-2A6B-43AB-BED6-C37EE1E1D2E2Q47804073-E77D5E79-6618-41CE-8F30-2C5462E926EAQ50922944-FC7A2830-5724-4280-86EE-8DFA6A933569
P2860
Tyrosine kinase signalling in breast cancer: insulin-like growth factors and their receptors in breast cancer.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Tyrosine kinase signalling in ...... eir receptors in breast cancer
@nl
Tyrosine kinase signalling in ...... ir receptors in breast cancer.
@ast
Tyrosine kinase signalling in ...... ir receptors in breast cancer.
@en
Tyrosine kinase signalling in ...... ir receptors in breast cancer.
@en-gb
type
label
Tyrosine kinase signalling in ...... eir receptors in breast cancer
@nl
Tyrosine kinase signalling in ...... ir receptors in breast cancer.
@ast
Tyrosine kinase signalling in ...... ir receptors in breast cancer.
@en
Tyrosine kinase signalling in ...... ir receptors in breast cancer.
@en-gb
prefLabel
Tyrosine kinase signalling in ...... eir receptors in breast cancer
@nl
Tyrosine kinase signalling in ...... ir receptors in breast cancer.
@ast
Tyrosine kinase signalling in ...... ir receptors in breast cancer.
@en
Tyrosine kinase signalling in ...... ir receptors in breast cancer.
@en-gb
P2860
P921
P356
P1476
Tyrosine kinase signalling in ...... eir receptors in breast cancer
@en
P2093
P2860
P2888
P304
P356
10.1186/BCR50
P407
P50
P577
2000-03-06T00:00:00Z
P5875
P6179
1053543974